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Abstract
Background: Recurrent pyogenic cholangitis (RPC) is still a common disease in East Asia. The present
study reviews the operative results for this disease in a single centre.
Methods: The records of 85 patients who underwent surgical treatment for RPC from August 1995 to
March 2008 were retrospectively reviewed.
Results: Patients included 35 men and 50 women with a median age of 61 years. Types of surgery
included: hepatectomy (65.9%); hepatectomy plus drainage (9.4%); drainage alone (14.1%), and percu-
taneous choledochoscopy (10.6%). There was no operative mortality. Complications occurred in 40% of
patients and half the complications involved wound infections. The overall incidences of residual stone,
stone recurrence and biliary sepsis recurrence were 21.2%, 16.5% and 21.2%, respectively, over a
median follow-up of 45.4 months. The drainage-alone group and percutaneous choledochoscopy group
had higher incidences of residual stone, stone recurrence and biliary sepsis recurrence. In hepatectomy
patients, regardless of whether or not a drainage procedure had been performed, rates of residual stone,
stone recurrence and biliary sepsis recurrence were 15.6%, 7.8% and 9.4%, respectively, over a median
follow-up of 42.7 months.
Conclusions: Hepatectomy is safe and yields the best treatment outcome for RPC. It should be
considered as the treatment of choice for suitable patients with RPC.
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Introduction
Recurrent pyogenic cholangitis (RPC) is a peculiar disease entity
commonly found in East Asia.1–4 It is a progressive biliary disease
that involves diffuse biliary tract ectasia and primary stone for-
mation. Morphologically, it is characterized by pigmented ductal
stone and ductal stricture (intrahepatic and/or extrahepatic), cis-
ternal dilatation of the proximal ducts, hepatic segmental or lobar
atrophy, thrombosis of the portal vein tributaries, superimposed
cholangiocarcinoma and biliary cirrhosis. Patients usually present
with repeated episodes of bacterial cholangitis. Some patients may
present with acute pancreatitis, liver abscess or abdominal pain.
Management of RPC is difficult because of the presence of deep-
seated intrahepatic ductal stones and ductal strictures, which are
often multiple. Endoscopic therapy in terms of biliary stenting,
stone retrieval and stricture dilatation is useful in emergency situ-
ations or as a temporary measure. Surgical treatment remains the
definitive and radical treatment for RPC to prevent stone forma-
tion and recurrent attacks of cholangitis.
Materials and methods
We performed a retrospective review of 85 patients with RPC who
received surgical treatment from August 1995 to March 2008 in
the Department of Surgery, Prince of Wales Hospital, Chinese
University of Hong Kong. The diagnosis of RPC was based on
clinical and radiological findings (Fig. 1).5–7 Histological confir-
mation was available for 64 patients who had undergone hepate-
ctomy. Demographic data, investigation results, operative findings
and follow-up details were analysed. We focused on the documen-
tation of residual and recurrent stone, recurrent cholangitis and
the development of cholangiocarcinoma.
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Residual stone was defined as incomplete stone clearance as
revealed during surgery by intraoperative ultrasound or cholang-
iography, or by imaging results obtained within 3 months of
surgery. The time interval of 3 months was chosen according to a
recent study by Lee et al.8 Recurrent stone was defined as new
stone formation as shown on imaging or endoscopic retrograde
cholangiopancreatography (ERCP) >3 months after initial com-
plete clearance by operation. Survival was calculated using the
Kaplan–Meier method.
Choices of surgical treatment
In general, surgical treatment was offered if the patient suffered
repeated cholangitic attacks as a result of RPC. Treatment options
included liver resection, biliary drainage alone, combined liver
resection and biliary drainage, and percutaneous choledochos-
copy. The choice of therapy was decided according to the patient’s
condition, such as fitness for general anaesthesia, tolerance for
hepatectomy, previous treatment failure, multiple previous opera-
tions and local anatomical factors. Liver resection was considered
for atrophic liver lobe or segment, lobe- or segment-predominant
disease, or suspected cholangiocarcinoma. Drainage procedures
were indicated for main duct stricture, grossly dilated common
duct with bile stasis problems or if common bile duct stones
recurred. Biliary drainage was usually performed as a hepaticoje-
junostomy with or without the creation of an access loop to
facilitate the subsequent retrieval of recurrent stones. Other less
commonly used drainage procedures included transduodenal
sphincteroplasty or T-tube drainage. If patients were unfit for
general anaesthesia, percutaneous choledochoscopic removal of
stones or fragmentation of stones could be performed under local
anaesthesia after serial dilatation of the percutaneous transhepatic
biliary tract. Tract choledochoscopy was the preferred option
when a patient had recurrent stones after previous hepatectomy or
drainage procedures. Except for cases undergoing percutaneous
choledochoscopy, cholecystectomy would be performed during
surgery for concurrent gallstones or for the prevention of subse-
quent cholelithiasis. The clearance of the common bile duct would
also be confirmed by exploration through the ductal opening at
the transected liver surface or direct choledochotomy.
Results
The study included 35 men and 50 women with a median age of
61 years (range 27–85 years). The initial presenting features of the
patients were as follows: acute cholangitis (50.6%); abdominal
pain (32.9%); jaundice (8.2%); acute pancreatitis (3.5%); liver
abscess (3.5%), and incidental findings (1.2%). The median dura-
tion of RPC was 24 months, but one patient was known to have
had the disease for 34 years. A total of 37 patients (43.5%) had
undergone previous biliary surgery, of whom eight had under-
gone two previous operations and two had undergone three.
Types of previous operations are shown in Table 1. All except six
patients had ERCP before the index surgery. The average number
of ERCP procedures performed before surgery was 2.8. One
patient had undergone 10 ERCPs before surgery. By contrast, 28
patients (32.9%) had undergone percutaneous transhepatic
biliary drain (PTBD) insertion before surgery.
Disease distribution in the liver lobes was recorded in 82
patients. In the majority of patients, disease was confined to the
left liver lobe (64.6%). Only 4.9% of patients had isolated right
lobe RPC. Bilobar involvement occurred in 30.5% of patients.
Atrophic liver segments or lobe occurred in 49 (64.5%) of 76
patients. Major ductal strictures occurred in 41 (51.3%) of 80
patients. Gallstones were found in 43.9% of patients who had no
previous cholecystectomy, whereas common bile duct stones were
found in 27.2% patients who had no previous bile duct resection.
Excluding cholecystectomy and exploration of the bile duct,
which may constitute parts of the operations, the types of
operative procedures performed are shown in Table 2. There was
no in-hospital or 30-day mortality. Forty-six complications
Figure 1 Computed tomography revealed multiple intrahepatic
ductal stones and ectatic intrahepatic ducts compatible with recur-
rent pyogenic cholangitis
Table 1 Types of previous operation
Types of previous operation No. of operations
Cholecystectomy 22 (44.9%)
Cholecystectomy + ECBD 2 (4.1%)
ECBD 7 (14.3%)
Drainage procedure 6 (12.2%)
Cholecystectomy + drainage procedure 7 (14.3%)
Hepatectomy 3 (6.1%)
Choledochoscopy 2 (4.1%)
Total 49 (100%)
ECBD, exploration of common bile duct
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occurred in 34 patients (40%) (Table 3). No patient required
re-operation, but five patients required ultrasound guided per-
cutaneous drainage. Median blood loss was 350 ml (range
0–3600 ml). Fourteen patients (16.5%) required blood transfu-
sion. The median postoperative hospital stay was 12 days (range
1–55 days).
Bile was sent for culture in 64 patients. The bile was obtained
during ERCP, PTBD or surgery. Culture results were positive in 59
patients (92.2%), 45 of whom (76.3%) had positive culture for
multiple organisms (up to six types). Types of organisms are
shown in Table 4. Positive culture results were also obtained from
infected wounds, drained fluid, pleural fluid or bile leak after
surgery in 30 patients; organisms found are shown in Table 4.
Histological results were available in 64 patients who under-
went hepatectomy. All of them showed features of RPC. Four
patients also had background liver cirrhosis. Three patients were
found to have clonorchis sinesis infestation. Five patients had
histological evidence of cholangiocarcinoma. Two of these five
patients were diagnosed with cholangiocarcinoma before surgery
and the other three were diagnosed after surgery.
These 85 patients were followed for a median period of 45.4
months (range 2.6 months to 12.7 years). The 5-year survival was
87.3%. Eleven patients died during this period. Causes of death
were cholangiocarcinoma in three patients and other malignant
diseases in six patients. Of the remaining two patients, one died
of cirrhosis and the other committed suicide. Three of the five
cholangiocarcinoma patients had recurrent disease during the
follow-up period and two of them died of the disease. One addi-
tional case of cholangiocarcinoma was diagnosed 2 years after
surgery and died subsequently. All six cases of cholangiocarci-
noma occurred in the group that underwent hepatectomy with or
without a drainage procedure.
Overall, residual stones occurred in 18 patients (21.2%) and a
further 14 patients (16.5%) developed recurrent stones after initial
complete clearance. Fourteen patients had recurrent cholangitis
and four patients had liver abscess during follow-up (Table 5).
No patient died of biliary sepsis. The group that underwent
Table 2 Types of surgical procedure
Types of surgical procedure No. of patients
Hepatectomy 56 (65.9%)
Left hepatectomy 13 (15.3%)
Left lateral sectionectomy 40 (47.1%)
Right hepatectomy 2 (2.4%)
Right posterior sectionectomy 1 (1.2%)
Hepatectomy + drainage procedure 8 (9.4%)
Left hepatectomy + HJ 2 (2.4%)
Left lateral sectionectomy + HJ 4 (4.7%)
Left lateral sectionectomy + sphincteroplasty 1 (1.2%)
Right hepatectomy + HJ 1 (1.2%)
Drainage procedure 12 (14.1%)
Hepaticojejunostomy 6 (7.1%)
Transduodenal sphincteroplasty 1 (1.2%)
T-tube drainage 5 (5.9%)
Percutaneous choledochoscopy 9 (10.6%)
Total 85 (100%)
HJ, hepaticojejunostomy +/- access loop
Table 3 Postoperative complications
Types of complication Frequency
Wound infection 23 (50%)
Intra-abdominal collection 10 (21.7%)
Pleural effusion 3 (6.5%)
Bile leak 2 (4.3%)
Atrial fibrillation 2 (4.3%)
Wound dehiscence 1 (2.2%)
Incisional hernia 1 (2.2%)
Others 4 (8.7%)
Table 4 Culture results
Types of organism Pre- and
intraoperative
bile culture
Postoperative
culture from
infected sites
Escherichia coli 34 (24.8%) 7 (15.9%)
Enterococcus 26 (19.0%) 9 (20.5%)
Pseudomonas 19 (13.9%) 10 (22.7%)
Klebsiella 17 (12.4%) 8 (18.2%)
Streptococcus 9 (6.6%) 0 (0%)
Citrobacter 6 (4.4%) 0 (0%)
Enterobacter 5 (3.6%) 3 (6.8%)
Aeromonas hydrophilia 4 (2.9%) 3 (6.8%)
Others 17 (12.4%) 4 (9.1%)
Total 137 (100%) 44 (100%)
Table 5 Stone clearance, stone recurrence and biliary sepsis recurrence in different treatment groups
Stone clearance Stone recurrence Biliary sepsis recurrence
Hepatectomy (n = 56) 48 (85.7%) 5 (8.9%) 4 (7.1%)
Hepatectomy + drainage procedure (n = 8) 6 (75.0%) 0 (0%) 2 (25.0%)
Drainage procedure (n = 12) 8 (66.7%) 6 (50.0%) 10 (83.3%)
Percutaneous choledochoscopy (n = 9) 5 (55.6%) 3 (33.3%) 2 (22.2%)
Total (n = 85) 67 (78.8%) 14 (16.5%) 18 (21.2%)
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percutaneous choledochoscopy had the lowest rate of stone clear-
ance (55.6%), and the group that underwent a drainage procedure
alone carried the highest rates of stone recurrence (50.0%) and
recurrent biliary sepsis (83.3%). Both the hepatectomy-alone
group and the hepatectomy-plus-drainage-procedure group had
high stone clearance rates (85.7% and 75.0%, respectively) and low
stone recurrence rates (8.9% and 0%, respectively). Further com-
bined analysis of these two groups of hepatectomy patients (n =
64), regardless of whether they underwent a concomitant drainage
procedure, showed rates for stone clearance, stone recurrence and
biliary sepsis recurrence to be 84.4%, 7.8% and 9.4%, respectively,
over a median follow-up period of 42.7 months.The morbidity rate
was 42.2%. The proportion of bilobar involvement of disease was
26.6% in this group of patients (Table 6).
Discussion
Recurrent pyogenic cholangitis is also commonly known as hepa-
tolithiasis or intrahepatic stones. We prefer to describe the disease
as RPC because it can involve the extrahepatic duct and gallblad-
der. In this study, 27.2% of patients had common bile duct stones
and 43.9% patients had gallstones. However, the term ‘hepatolithi-
asis’ implies the presence of stones in intrahepatic ducts, which is
also a feature of other diseases such as primary sclerosing cholan-
gitis (PSC), postoperative stricture or malignant disease. The term
‘recurrent pyogenic cholangitis’ was first used by Cook et al. as
early as 1954, although the disease was first described by Digby in
1930.1,2 It is prevalent in East Asians and Latin Americans, in lower
socioeconomic groups and in people who live in rural environ-
ments. There is no gender difference in incidence of the disease
and the peak incidence occurs in the third to fourth decades of
life.3 The incidence of RPC is declining in East Asia, but it is
increasing in the West as a result of immigration.9 A nationwide
survey carried out in Japan in the 1970s revealed that RPC
accounted for 4.1% of patients with biliary calculi who underwent
surgery.10 Recurrent pyogenic cholangitis is characterized by
repeated primary infection of the biliary system by pus-forming
bacteria and the development of pigmented stones and ductal
strictures. The formation of stones is thought to result from the
action of bacterial b-glucuronidase on conjugated bilirubin.3 The
organisms are enteric in origin and gain access to the liver through
the portal vein.
During an acute attack of cholangitis, the management of RPC
is similar to that of cholangitis secondary to gallstone. The
primary aim is to control sepsis with antibiotics and biliary drain-
age. The PTBD procedure may be used more frequently if there is
obstruction at the intrahepatic level. The definitive treatment of
RPC aims to remove all stones, correct anatomical abnormalities
or the source of infections, prevent recurrent attacks of cholangitis
and stop the progression of the disease, which can lead to biliary
cirrhosis. Various surgical options can be adopted according to
disease distribution, the location of significant strictures, the pres-
ence of liver atrophy and the presence of suspected superimposed Ta
b
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cholangiocarcinoma. Other factors also affect the choice of treat-
ment as many patients have a longstanding history of disease(s)
and may have undergone multiple ERCPs and previous surgery.
However, we recommend that the gallbladder is removed and the
common bile duct cleared at the time of surgery because
co-existing gallstones and common bile duct stones occur in
43.9% and 27.2% of patients, respectively. Even in the absence of
gallstones, prophylactic cholecystectomy will eliminate the need
for a potentially difficult second operation if subsequent
cholelithiasis or cholecystitis occurs.
We adopted different treatment approaches for different
patients, with satisfactory results. No surgery-related deaths
occurred. Complications occurred in 40% of patients, half of
which were wound infections. It was not surprising that infective
complications occurred so frequently because 92.2% of preopera-
tive or intraoperative bile culture results were positive. Hence it is
important to give appropriate prophylactic antibiotics according
to culture result as the organisms identified from infected sites
after surgery were quite similar (Table 4). In order to reduce the
rate of wound infection, we routinely packed the wound with
saline gauze after surgery and left it to heal by secondary intention.
The median blood loss (350 ml) and blood transfusion rate
(16.5%) were acceptable and patients were able to be discharged
after a median postoperative hospital stay of 12 days.
Overall rates for residual stones, stone recurrence and biliary
sepsis recurrence were 21.2%, 16.5% and 21.2%, respectively,
during follow-up. As Table 5 shows, the hepatectomy group
achieved the most favourable results, whereas both the drainage-
alone and the percutaneous choledochoscopy groups performed
badly in these three parameters. Hepaticojejunostomy and T-tube
drainage were shown to have high residual stone rates (25.9%)
and postoperative cholangitis (24%) in one recent retrospective
study.11 Another study comparing four different treatment
approaches for hepatolithiasis also showed that hepatectomy
achieved a better result than hepaticojejunostomy, T-tube drain-
age and percutaneous choledochoscopy.12
If we combine the hepatectomy group of patients with the
hepatectomy-plus-drainage-procedure group, the total number
of patients who received hepatectomy for RPC amounts to 64.
Outcomes for these 64 patients are compared with outcomes in
recent series of hepatectomy for RPC in Table 6.8,12–16 Mortality
and morbidity rates and the incidence of cholangiocarcinoma in
this study are similar to those in other series. Although we
achieved the lowest stone clearance rate of 84.4%, our rates for
stone and biliary sepsis recurrence are comparable with those in
other series. This implies that although more stones were
retained after surgery, such stone retention may not translate to
a higher incidence of clinical problems as manifested by cholan-
gitis or liver abscess during follow-up. The high rate of residual
stones in our series may reflect the higher proportion of bilobar
disease in our series (26.6%) compared with those in other series
(7.9–17.3%) (Table 6). In these patients, we accept the presence
of some residual peripheral stones in the contralateral lobe after
hepatectomy as our aim is to prevent recurrent stone formation,
recurrent attacks of biliary sepsis and the occurrence of
cholangiocarcinoma.
As we have shown, hepatectomy is safe for RPC and achieves the
best possible results in terms of providing longterm relief of the
disease; thus, we would recommend hepatectomy as the treatment
of choice for RPC whenever possible. Indications for hepatectomy
should be extended to patients with bilobar disease as residual
stones in the less affected liver lobe may not cause subsequent
clinical problems, as shown by our study. Cholecystectomy, explo-
ration of the bile duct and drainage procedures alone may delay
definitive treatment and make subsequent operative intervention
difficult. Although percutaneous choledochoscopy was shown to
have a satisfactory stone clearance rate of 85.3% in one large series
of 245 patients, the overall rate for stone recurrence and/or cho-
langitis was 63.2% after a mean follow-up of 10.3 years.17 The
same group showed a similar result even when percutaneous cho-
ledochoscopy was used as the primary treatment for hepatolithi-
asis.18 In another study that compared hepatectomy with
percutaneous choledochoscopy for hepatolithiasis, both treat-
ments were found to result in satisfactory rates of stone clearance,
but stone recurrence in the percutaneous choledochoscopy group
was much higher than in the hepatectomy group (31.5% vs.
5.6%).19 Thus percutaneous choledochoscopy cannot be recom-
mended as a definitive treatment in low-risk patients.
Conclusions
Hepatectomy is safe and yields the best treatment outcome for
patients with RPC. Hepatectomy is desirable in the presence of
atrophic liver segment or lobe, segment- or lobe-dominant disease,
and in cases of suspected cholangiocarcinoma. The anticipation of
incomplete stone clearance should not represent an obstacle to
hepatectomy because incomplete clearance may not translate into
a clinical problem. Drainage procedures alone and percutaneous
choledochoscopy have high incidences of residual stone, stone
recurrence and biliary sepsis recurrence. However, these proce-
dures may be useful in the treatment of frail, elderly patients, and in
those with complicated disease or previous hepatectomy.
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